We have heard a lot about the ‘patent expiry’ problem within the industry. Here are 5 +1 steps your IT team can take to help improve a company’s position to meet this challenge. As revenues decline as a result of ‘patent expiry’ there is an associated ‘cost reduction’ that is taking place. This is not Read More
Tag: process innovation
Aligning Life Sciences and Healthcare IT. Part 3 Innovation and the Business Process
This is the last installment on Aligning Life Sciences and Healthcare IT. I had written two earlier blog posts on Innovation back on 23Nov2009 The time for ‘Process Innovation’ is now and on 8Dec2009 Pharma 2.0 and the need for Process Innovation. I had been inspired to write about this topic due to a recent set of tweets Read More
New Research Model to Accelerate Drug Development
Online Webinar (25March2010) on “Developing Cures with Less Time and Capital” discusses a new research model for drug development. With the focus on healthcare costs, what can be done to improve success in developing new treatments? How can this model help the pharmaceutical industry gain a greater ROI around drug development?
Cloud Computing and Life Sciences IT
Leveraging IT for Life Sciences and Healthcare: in Cloud Computing and Life Sciences IT we discuss learning effective ways to bring in innovation within your IT budget. What is cloud computing and how could it work within the Life Sciences industy.
Upgrading for 2010
I’m not very good at keeping New Year’s resolutions. Yet what I intend to do this year is to align my interests with what I am currently doing. At present I am contracting with an IT service provide to ‘start-up’ a new Life Sciences practice. So in keeping with the title of my blog, how Read More
Pharma 2.0 and the need for Process Innovation
I read an article by Stephanie Sutton, PharmaTech Europe entitled The Pharma 2.0 Trend for 2010. The article summarizes how the industry will remain status quo for 2010 based on Ovum’s industry report. “The trend for slow growth will continue, and cutting costs and reducing time–to-market will remain a priority, particularly with the impending patent Read More